The future of antigen-specific immunotherapy of allergy (Q34716363)

4 August 2017

1 reference

title

The future of antigen-specific immunotherapy of allergy (English)

1 reference

4 August 2017

1 reference

1

Rudolf Valenta

1 reference

4 August 2017

1 June 2002

1 reference

Nature Reviews Immunology

4 August 2017

1 reference

4 August 2017

2

1 reference

4 August 2017

6

1 reference

4 August 2017

446-453

1 reference

https://scigraph.springernature.com/pub.10.1038/nri824

4 August 2017

0 references

cites work

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

1 reference

The germless theory of allergic disease: revisiting the hygiene hypothesis.

31 March 2020

1 reference

Recombinant allergen molecules: tools to study effector cell activation

31 March 2020

1 reference

A genome-wide search for quantitative trait loci underlying asthma

31 March 2020

1 reference

A first trial of retrospective collaboration for positional cloning in complex inheritance: assay of the cytokine region on chromosome 5 by the consortium on asthma genetics (COAG).

31 March 2020

1 reference

A major susceptibility locus for atopic dermatitis maps to chromosome 3q21.

31 March 2020

1 reference

Indoor allergen exposure is a risk factor for sensitization during the first three years of life

31 March 2020

1 reference

Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

31 March 2020

1 reference

Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms

31 March 2020

1 reference

The dendritic cell in allergic airway diseases: a new player to the game

31 March 2020

1 reference

Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

31 March 2020

1 reference

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

31 March 2020

1 reference

Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio

31 March 2020

1 reference

Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells

31 March 2020

1 reference

Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy

31 March 2020

1 reference

Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure

31 March 2020

1 reference

Retention of long-lived, allergen-specific T cells in atopic dermatitis skin -letter-.

31 March 2020

1 reference

Expression of ɛ germ-line gene transcripts and mRNA for the ɛ heavy chain of IgE in nasal B cells and the effects of topical corticosteroid

31 March 2020

1 reference

Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

31 March 2020

1 reference

Persistent IgE synthesis in the nasal mucosa of hay fever patients

31 March 2020

1 reference

Allergen-specific IgE production of committed B cells from allergic patients in vitro

31 March 2020

1 reference

Effects of IL-4 and IL-13 on total and allergen specific IgE production by cultured PBMC from allergic patients determined with recombinant pollen allergens

31 March 2020

1 reference

Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5.

31 March 2020

1 reference

Maximal rise in IgE antibody following ragweed pollination season

31 March 2020

1 reference

Nasal provocation with allergen induces a secondary serum IgE antibody response

31 March 2020

1 reference

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

31 March 2020

1 reference

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

31 March 2020

1 reference

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

31 March 2020

1 reference

Signalling through the high-affinity IgE receptor Fc epsilonRI.

31 March 2020

1 reference

The relationship between serum IgE and surface levels of FcϵR on human leukocytes in various diseases: Correlation of expression with FcϵRI on basophils but not on monocytes or eosinophils

31 March 2020

1 reference

Drastic up-regulation of Fcepsilonri on mast cells is induced by IgE binding through stabilization and accumulation of Fcepsilonri on the cell surface

31 March 2020

1 reference

Regulation of mast cell survival by IgE

31 March 2020

1 reference

Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival

31 March 2020

1 reference

The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes

31 March 2020

1 reference

High-affinity IgE receptor on eosinophils is involved in defence against parasites

31 March 2020

1 reference

Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein

31 March 2020

1 reference

Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics.

31 March 2020

1 reference

Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma

31 March 2020

1 reference

Antigen-specific T cell tolerance down-regulates mast cell responses in vivo

31 March 2020

1 reference

Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors

31 March 2020

1 reference

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

31 March 2020

1 reference

Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity

31 March 2020

1 reference

Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation

31 March 2020

1 reference

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

31 March 2020

1 reference

Eosinophils, allergy and parasites

31 March 2020

1 reference

Eosinophils generate brominating oxidants in allergen-induced asthma

31 March 2020

1 reference

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

31 March 2020

1 reference

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

31 March 2020

1 reference

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

31 March 2020

1 reference

B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy

31 March 2020

1 reference

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

31 March 2020

1 reference

Immunologic changes associated with allergen immunotherapy

31 March 2020

1 reference

SEROLOGICAL EVIDENCE OF IMMUNITY WITH COEXISTING SENSITIZATION IN A TYPE OF HUMAN ALLERGY (HAY FEVER).

31 March 2020

1 reference

Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody

31 March 2020

1 reference

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

31 March 2020

1 reference

Generation of Antigen-Specific Suppressor Cells during Allergy Desensitization

31 March 2020

1 reference

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

31 March 2020

1 reference

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

31 March 2020

1 reference

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

31 March 2020

1 reference

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

31 March 2020

1 reference

Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens

31 March 2020

1 reference

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

31 March 2020

1 reference

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

31 March 2020

1 reference

Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats

31 March 2020

1 reference

Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects

31 March 2020

1 reference

Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects

31 March 2020

1 reference

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

31 March 2020

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

31 March 2020

1 reference

Abrogation of reaginic antibodies with modified allergens

31 March 2020

1 reference

False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens☆☆☆★★★

31 March 2020

1 reference

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

31 March 2020

1 reference

Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals

31 March 2020

1 reference

Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System

31 March 2020

1 reference

IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE

31 March 2020

1 reference

Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations

31 March 2020

1 reference

Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy.

31 March 2020

1 reference

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy

31 March 2020

1 reference

Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

31 March 2020

1 reference

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

31 March 2020

1 reference

Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

31 March 2020

1 reference

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

31 March 2020

1 reference

Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.

31 March 2020

1 reference

Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1

31 March 2020

1 reference

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.

31 March 2020

1 reference

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

31 March 2020

1 reference

C8/119S mutation of major mite allergen Derf-2 leads to degenerate secondary structure and molecular polymerization and induces potent and exclusive Th1 cell differentiation.

31 March 2020

1 reference

Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.

31 March 2020

1 reference

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the

31 March 2020

1 reference

Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen

31 March 2020

1 reference

Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population

31 March 2020

1 reference

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

31 March 2020

1 reference

Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season

31 March 2020

1 reference

Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.

31 March 2020

1 reference

Activation of B-lymphocytes during pollen season. Effect of immunotherapy

31 March 2020

1 reference

Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells

31 March 2020

1 reference

Grass pollen immunotherapy decreases the number of mast cells in the skin.

31 March 2020

1 reference

Dimensions Publication ID

31 March 2020

Identifiers

DOI

10.1038/NRI824

0 references

0 references

1 reference

PubMed ID

12093011